Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:00 pm Sale |
2024-12-31 | 13G | Cue Biopharma, Inc. CUE |
Slate Path Capital LP | 918,836 1.400% |
-1,483,619 (-61.75%) |
Filing History |
| 2024-12-06 4:05 pm Sale |
2024-11-30 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 0 0.000% |
-357,880 (Position Closed) |
Filing History |
| 2024-01-22 3:44 pm Purchase |
2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 357,880 14.600% |
357,880 (New Position) |
Filing History |
| 2023-02-14 09:30 am Unchanged |
2022-12-31 | 13G | Cue Biopharma, Inc. CUE |
Slate Path Capital LP | 2,402,455 5.600% |
0 (Unchanged) |
Filing History |
| 2023-02-14 09:30 am Sale |
2022-12-31 | 13G | Stitch Fix, Inc. SFIX |
Slate Path Capital LP | 0 0.000% |
-4,282,056 (Position Closed) |
Filing History |
| 2023-01-13 4:30 pm Unchanged |
2022-11-01 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 357,880 16.500% |
0 (Unchanged) |
Filing History |
| 2022-11-18 4:04 pm Purchase |
2022-11-16 | 13G | Cue Biopharma, Inc. CUE |
Slate Path Capital LP | 2,402,455 5.600% |
2,402,455 (New Position) |
Filing History |
| 2022-10-21 5:13 pm Unchanged |
2022-10-21 | 13D | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 357,880 16.500% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:15 pm Purchase |
2021-12-31 | 13G | Zimmer Energy Transition Acquisition Corp. ZT |
Slate Path Capital LP | 2,000,000 5.800% |
2,000,000 (New Position) |
Filing History |
| 2022-02-11 4:44 pm Sale |
2021-12-31 | 13G | Warner Music Group Corp. WMG |
Slate Path Capital LP | 3,134,779 2.550% |
-1,355,221 (-30.18%) |
Filing History |
| 2022-02-11 4:43 pm Purchase |
2021-12-31 | 13G | Hippo Holdings Inc. HIPO |
Slate Path Capital LP | 14,000 0.060% |
14,000 (New Position) |
Filing History |
| 2022-02-11 4:41 pm Purchase |
2021-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 357,880 16.490% |
48,077 (+15.52%) |
Filing History |
| 2022-02-11 4:40 pm Purchase |
2021-12-31 | 13G | Stitch Fix, Inc. SFIX |
Slate Path Capital LP | 4,282,056 5.140% |
4,282,056 (New Position) |
Filing History |
| 2022-02-11 4:39 pm Purchase |
2020-12-31 | 13G | 5:01 Acquisition Corp. FVAM |
Slate Path Capital LP | 500,000 5.800% |
500,000 (New Position) |
Filing History |
| 2021-02-16 07:03 am Purchase |
2020-12-31 | 13G | Warner Music Group Corp. WMG |
Slate Path Capital LP | 4,490,000 5.070% |
4,490,000 (New Position) |
Filing History |
| 2021-02-16 07:03 am Purchase |
2020-12-31 | 13G | REINVENT TECHNOLOGY PARTNERS Z RTPZU |
Slate Path Capital LP | 1,750,000 7.610% |
1,750,000 (New Position) |
Filing History |
| 2020-08-10 4:16 pm Purchase |
2020-07-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Slate Path Capital LP | 309,803 18.300% |
309,803 (New Position) |
Filing History |